Form D · Other
Teiko Bio, Inc.
Salt Lake City, UT · CIK 0001885101
Offering snapshot reported Oct 5, 2021 · SEC filing
- Reported sold
- $11.6M Offering amount: $15.3M
- Investors reported
- 40 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 22, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 5, 2021 | Initial | $11,639,995 | No comparison | 40 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-415696
Total Amount Sold includes cancellation of debt.
Source: Form D, filed Oct 5, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Matthew Spitzer | Director |
| Ramji Srinivasan | Director, Executive |
| Victor Wang | Director |
Issuer details
Industry: Other (See others in industry)
Address:
630 S. Komas Drive
Salt Lake City, UT, 84108
Salt Lake City, UT, 84108